Royalty Pharma plc has announced a significant update to its financial arrangements with the entry into a Joinder, Release and First Amendment to its Loan Agreement and Loan Documents. Following the consummation of a transaction, RP Management has been released as a borrower under the existing loan agreement and guaranty, which were originally dated December 11, 2023. In their place, RPH and RP LLC have been joined as borrowers and guarantors under the amended agreements. Additionally, the Entity Guarantors, Legorreta Investments and Legorreta Investments II LLC, along with Individual Guarantor Pablo Legorreta, have confirmed their ongoing obligations under the revised terms. This amendment signifies the restructuring of Royalty Pharma's financial commitments in collaboration with Bank of America, N.A.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。